Literature DB >> 20586551

Clinical, ultrasonographic, computed tomography and histopathological manifestations of ovarian steroid cell tumour, not otherwise specified: our experience of a rare case with female virilisation and review of the literature.

Michail Varras1, Thivi Vasilakaki, Evangelia Skafida, Chistodoulos Akrivis.   

Abstract

INTRODUCTION: Ovarian steroid cell tumours, not otherwise specified (NOS) are rare sex cord-stromal tumours of the ovary. These tumours should be considered a cause of isosexual precocious puberty in children and virilisation in adults. CASE: We report a case of 40-year-old woman with mental handicap who presented with 3 years of amenorrhea and progressive virilisation. Pelvic ultrasonography identified a 6.19 × 6.15 cm well-defined echogenic-multilobular mass arising from the left ovary. Fluid in the cul-de-sac was noted. Colour Doppler examination with endovaginal ultrasonography showed high vascularity of the tumour with low resistance to flow. A computed tomography (CT) scan of the upper and lower abdomen showed a lobular mass with diaphragms in the left adnexal structure and fluid in the cul-de-sac; no adrenal gland enlargement or additional tumour was detected. Laboratory analysis revealed increased levels of serum total testosterone. Total abdominal hysterectomy with bilateral salpingo-oophorectomy was performed. Histological examination showed a benign steroid cell tumour, NOS without evidence of necrosis, haemorrhage or invasion. The immunohistochemical study showed that the tumour cells were positive for inhibin, CD 99, Melan A and vimentin and negative to CK AE1, CK AE3, progesterone and estrogen receptors.
CONCLUSION: Careful medical history, physical examination, laboratory serum values and imaging studies are helpful in making the pre-operative diagnosis. Steroid cell tumours, NOS are usually benign, unilateral and characterised by the composition of two similar-appearing polygonal cell types. They differ from Leydig cell tumours in the lack of crystals of Reinke in their cytoplasm.

Entities:  

Mesh:

Year:  2010        PMID: 20586551     DOI: 10.3109/09513590.2010.495432

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  5 in total

1.  Paraneoplastic erythrocytosis in a malignant ovarian steroid cell tumour.

Authors:  Rimpy Tandon; Poonam Goel; Shailja Kataria; Pradip Kumar Saha; R P S Punia; Kislay Dimri
Journal:  Indian J Hematol Blood Transfus       Date:  2012-09-18       Impact factor: 0.900

2.  A rare cause of virilization; Ovarian steroid cell tumor, not otherwise specified (NOS).

Authors:  Nicel Taşdemir; Cem Celik; Remzi Abalı; Erson Aksu; Meltem Oznur; Murat Yılmaz
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-12-01

3.  Hyperandrogenism, Elevated 17-Hydroxyprogesterone and Its Urinary Metabolites in a Young Woman with Ovarian Steroid Cell Tumor, Not Otherwise Specified: Case Report and Review of the Literature.

Authors:  Felix C K Wong; Angela Z Chan; W S Wong; Angel H W Kwan; Tracy S M Law; Jacqueline P W Chung; Jeffrey S S Kwok; Angel O K Chan
Journal:  Case Rep Endocrinol       Date:  2019-10-27

4.  Ovarian Steroid Cell Tumor (Not Otherwise Specified): A Case Report of Ovarian Hyperandrogenism.

Authors:  Hadjkacem Faten; Ghorbel Dorra; Charfi Slim; Safi Wajdi; Charfi Nadia; Chaabene Kais; Boudawara Tahia; Abid Mohamed
Journal:  Case Rep Oncol Med       Date:  2020-04-08

5.  Symptomatic Ovarian Steroid Cell Tumor not Otherwise Specified in a Post-Menopausal Woman.

Authors:  Neha Sood; Kaniksha Desai; Ana-Maria Chindris; Jason Lewis; Tri A Dinh
Journal:  Rare Tumors       Date:  2016-06-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.